Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

December 01, 2016; Volume 90,Issue 6

Minireviews

  • You have access
    For Better or Worse: FFAR1 and FFAR4 Signaling in Cancer and Diabetes
    J. M. Houthuijzen
    Molecular Pharmacology December 2016, 90 (6) 738-743; DOI: https://doi.org/10.1124/mol.116.105932
  • You have access
    The 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer
    Hannah E. Majeski and Jing Yang
    Molecular Pharmacology December 2016, 90 (6) 744-754; DOI: https://doi.org/10.1124/mol.116.106765

Articles

  • GluN2D-Containing N-methyl-<span class="sc">d</span>-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity
    You have access
    GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity
    Riley E. Perszyk, John O. DiRaddo, Katie L. Strong, Chian-Ming Low, Kevin K. Ogden, Alpa Khatri, Geoffrey A. Vargish, Kenneth A. Pelkey, Ludovic Tricoire, Dennis C. Liotta, Yoland Smith, Chris J. McBain and Stephen F. Traynelis
    Molecular Pharmacology December 2016, 90 (6) 689-702; DOI: https://doi.org/10.1124/mol.116.105130
  • You have access
    Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy
    Anh T.N. Nguyen, Jo-Anne Baltos, Trayder Thomas, Toan D. Nguyen, Laura López Muñoz, Karen J. Gregory, Paul J. White, Patrick M. Sexton, Arthur Christopoulos and Lauren T. May
    Molecular Pharmacology December 2016, 90 (6) 703-714; DOI: https://doi.org/10.1124/mol.116.105007
  • You have access
    Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity
    Anh T. N. Nguyen, Elizabeth A. Vecchio, Trayder Thomas, Toan D. Nguyen, Luigi Aurelio, Peter J. Scammells, Paul J. White, Patrick M. Sexton, Karen J. Gregory, Lauren T. May and Arthur Christopoulos
    Molecular Pharmacology December 2016, 90 (6) 715-725; DOI: https://doi.org/10.1124/mol.116.105015
  • You have access
    Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc
    Seiji Sato, Xi-Ping Huang, Wesley K. Kroeze and Bryan L. Roth
    Molecular Pharmacology December 2016, 90 (6) 726-737; DOI: https://doi.org/10.1124/mol.116.106112
  • You have access
    Molecular Basis for Inhibition of the Na+/Citrate Transporter NaCT (SLC13A5) by Dicarboxylate Inhibitors
    Ana M. Pajor, Cesar A. de Oliveira, Kun Song, Kim Huard, Veerabahu Shanmugasundaram and Derek M. Erion
    Molecular Pharmacology December 2016, 90 (6) 755-765; DOI: https://doi.org/10.1124/mol.116.105049
  • You have access
    State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281
    Marie-Laure Rives, Morena Shaw, Bin Zhu, Simon A. Hinke and Alan D. Wickenden
    Molecular Pharmacology December 2016, 90 (6) 766-774; DOI: https://doi.org/10.1124/mol.116.106575
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 90 (6)
Molecular Pharmacology
Vol. 90, Issue 6
1 Dec 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireviews
  • Articles
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics